Yasmeen Rahimi

Yasmeen Rahimi

Analyst-Equity presso Piper Sandler & Co. (Broker)

Finance
Consumer Services
Health Technology

Profilo

Dr. Yasmeen Rahimi is a Senior Research Analyst at Piper Sandler & Co. She is also a director covering biotechnology.
Prior to joining Piper Sandler in July 2020, Dr. Rahimi was a senior research analyst and co-head of biotechnology equity research team at ROTH Capital Partners.
Before that, she worked as an equity research associate at H.C.
Wainwright & Co. and Guggenheim Securities.
Prior to making the transition to Wall Street, Rahimi was a research scientist at Shire Pharmaceuticals where she developed biomarker strategies for a number of rare disease programs; she has an extensive expertise in liver metabolism.
She received her Ph.D.
from Indiana University School of Medicine.
In addition, she has a M.S.
in Bioanalytical Chemistry from Purdue University and a joint B.A.
in German and Chemistry from Butler University.

Posizioni attive di Yasmeen Rahimi

SocietàPosizioneInizio
Analyst-Equity 01/07/2020
Tutte le posizioni attive di Yasmeen Rahimi

Precedenti posizioni note di Yasmeen Rahimi

SocietàPosizioneFine
Direttore della Ricerca - Azioni 01/07/2020
Analyst-Equity 01/09/2017
Corporate Officer/Principal 01/06/2016
Corporate Officer/Principal 01/07/2015
Yale University Corporate Officer/Principal 01/11/2014
Vedi nel dettaglio l'esperienza di Yasmeen Rahimi

Formazione di Yasmeen Rahimi

The Indiana University School of Medicine Doctorate Degree
Purdue University Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Yasmeen Rahimi

Relazioni

100 +

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private5

Finance

Finance

Health Technology

Finance

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Yasmeen Rahimi